SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-20-005329
Filing Date
2020-11-02
Accepted
2020-11-02 16:15:59
Documents
5
Period of Report
2020-11-02

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 5871
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 9774
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 8466
4 GRAPHIC exhibit99-1x001.jpg GRAPHIC 8840
5 GRAPHIC exhibit99-2x001.jpg GRAPHIC 8761
  Complete submission text file 0001062993-20-005329.txt   49640
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36596 | Film No.: 201280643
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences